Innovation in point of care diagnostics for sepsis and bloodstream infections

Recording of the live webinar, broadcast on 26 November 2019:

Innovation in point-of-care diagnostics for sepsis and bloodstream infections

In this webinar, Till Bachmann gave an overview of recent advances in AMR diagnostics development. He discussed:
- State of the art approaches for diagnosing infections and AMR
- Pipeline of promising tests
- Challenges of adoption

Amrita Sukrity drew from her experience as a founder of SpotSense and talked about diagnosis of neonatal sepsis at the community level. Topics discussed included:
- Challenges across diagnosing newborn sepsis in NICU vs. in the community
- Identifying different phases of sepsis by combining risk parameters and biomarker data
- Creating outlines for biomarker-based differential diagnosis: work ahead

And finally, David Anderson’s presentation ‘CD64 as a host-response biomarker in sepsis and severe infections’ covered:
- Limitations of flow cytometry for CD64 as a diagnostic tool of sepsis and severe infections in emergency situations
- Novel observations on CD64 biology that should facilitate more sensitive a point-of-care (POC) diagnostic tests for sepsis and severe infections
- The ongoing development of a POC diagnostic test for neutrophil CD64

Moderator: Caroline Purslow, Nesta Challenges
Speakers: Till Bachmann, Amrita Sukrity, David Anderson

[Taranvir]

Really good work going on in the field of BSI and AMR . A great initiative by GARDP and brilliant work by the organizations working tirelessly for R&D in the field. Looks like we might have answer to these micro enemies in near future.